Study finds little benefit of Hydroxychloroquine against COVID-19

Coronavirus

FILE – This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine tablets in Las Vegas. According to results released on Thursday, May 7, 2020, a new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 consecutive patients treated at Columbia University Irving Medical Center in New York. (AP Photo/John Locher)

ALBANY, N.Y. (WSYR-TV) — A new study from the University of Albany and the State Health Department shows that Hydroxychloroquine has no benefit for coronavirus patients with or without Azithromycin.

The observational study looked at several questions, including how much physicians are prescribing Azithromycin or Z-Pack and/or Chloroquine for hospitalized COVID-19 patients and the effects they had.

Researchers looked at medical records for more than 1,400 patients from 25 hospitals in the New York City region who were admitted in the second half of March.

The study showed no positive adverse effects of the drug treatments — instead finding an associated apparent increase in cardiac arrest.


Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Johns Hopkins COVID-19 Live case map

Live Doppler 9 Map Center

CNY View

CNY View

CNY View

Oswego Area

Oswego Area

Syracuse Area

Syracuse Area